Relationship between IL-17_A and pneumococcal carriage in children aged under two years: data from a randomised

Zheng Quan Toh1, Yi Ying Ma1, Beth Temple2

  • 1Infection, Immunity and Global Health, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia; Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia.

Cytokine
|December 24, 2025
PubMed

Insights

Pneumococcal carriage in young children is linked to elevated levels of Interleukin-17A (IL-17A) and related cytokines. These findings suggest a role for IL-17A in pneumococcal carriage, but not its clearance in this age group.

Area of Science:

  • Immunology
  • Pediatrics
  • Microbiology

Background:

  • Pneumococcal carriage precedes invasive pneumococcal disease (IPD).
  • Interleukin-17A (IL-17A) and IL-17A-producing cells are implicated in pneumococcal carriage clearance in adults.
  • The role of IL-17A in pediatric pneumococcal carriage remains unclear.

Purpose of the Study:

  • To investigate the association between IL-17A, related cytokines (IL-22, IL-23, IFNγ), and IL-17A-producing cells with pneumococcal carriage in children under two years old.
  • To explore the relationship between these immune markers and the number of pneumococcal serotypes carried.

Main Methods:

  • Analysis of blood samples from 143 unvaccinated children at 18 months and nasopharyngeal swabs from birth to 24 months.
  • Measurement of plasma cytokine concentrations (IL-17A, IL-22, IL-23, IFNγ) using multiplex bead array or ELISA.
  • Quantification of IL-17A/IFNγ-producing cells via flow cytometry on peripheral blood mononuclear cells.

Main Results:

  • Higher plasma concentrations of IL-17A, IL-22, IL-23, and IFNγ were observed in pneumococcal carriers compared to non-carriers at 18 months.
  • Children carrying two or more pneumococcal serotypes exhibited significantly higher IL-17A, IL-22, and IL-23 levels.
  • No difference in IL-17A-producing cells was found between carriers and non-carriers; these cytokines did not predict pneumococcal clearance at 24 months.

Conclusions:

  • Pneumococcal carriage in children under two years is associated with elevated plasma IL-17A, IL-22, and IL-23 concentrations.
  • While associated with carriage, IL-17A and related cytokines do not appear to influence pneumococcal clearance in this age group.
Abstract

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.5K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.4K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
696
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
801
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
884